VENITI is dedicated to advancing the treatment of venous disease through clinical research and innovative technology and solutions. Partnering with leading physicians, VENITI has developed the VICI Venous Stent specifically for the challenges of treating iliofemoral venous outflow obstruction.


Boston Scientific Acquires VENITI

Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire VENITI, Inc., a privately-held company in Fremont, California which has developed and commercialized the VICI Venous Stent® System for treating venous obstructive disease. Boston Scientific has been an investor in VENITI since 2016.

When I was recruited to become CFO of Veniti it was a very easy decision for me. I really enjoy the healthcare space. With pharma or medical devices, every day is different.
- Catherine Matthes / CFO, VENITI